Obesity Clinical Trial
Official title:
Obese Patients Adhering to Mediterranean Diet Show Less Reduced Circulating Levels of Sirtuin 4
Verified date | July 2016 |
Source | Federico II University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Italy: Ethics CommitteeItaly: Ministry of Health |
Study type | Observational |
The Mediterranean diet (MD), a healthy dietary pattern based on some common dietary
characteristics in Mediterranean countries, is associated with high antioxidant capacity
linked to the low saturated fat intake that might contribute to reduce free fatty acid (FFA)
availability and oxidation in mitochondria, thus reducing the production of the reactive
oxygen species (ROS) superoxide, and promoting cellular health. To assess the adherence to
the MD, a simple 14-item questionnaire had been tested in different settings by the PREDIMED
(PREvención con DIeta MEDiterránea) multicenter, randomized, primary prevention trial. On
the other hand, to allow a more an accurate measurement of the actual macro and
micronutrient intakes, including dietary anti-oxidant micronutrients, the 7-day food records
is considered as the "gold standard" of self-administered food frequency questionnaires.
Circulating levels of Sirtuin 4 (Sirt4), part of a complex of proteins that control diverse
biological processes, including lipid metabolism, are low in obese patients, as a possible
attempt to decrease fat oxidative capacity and mitochondrial ROS production, however
promoting ectopic liver fat storage.
The phase angle (PA), a measure determined by bioelectrical impedance analysis (BIA), and
the visceral adiposity index (VAI), a gender-specific mathematical index based on simple
anthropometric and metabolic parameters, represent well-validated, reliable and widely used
markers of cellular health and ectopic adipose distribution and function, respectively. The
fatty liver index (FLI) is a surrogate measure for fatty liver recently proposed as an
independent predictor for diabetes mellitus.
Aim of the present study was to investigate in adult obese individuals the levels of Sirt4
according to the adherence to the MD evaluated by PREDIMED questionnaire, focusing on the
possible association with single dietary components evaluated by 7-day food records, and to
evaluate the association between circulating levels of Sirt4 and PA, as marker of cellular
health, VAI, as index of adipocyte dysfunction, and FLI, as a predictor of fatty liver.
Status | Completed |
Enrollment | 43 |
Est. completion date | January 2016 |
Est. primary completion date | December 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Adult obese subjects Exclusion Criteria: - Hypocaloric diet in the last three months or specific nutritional regimens, including vegan or vegetarian diets; - Presence of liver or renal failure, cancer, and acute or chronic inflammatory diseases based on a complete medical examination and laboratory investigations (psoriasis, rheumatoid arthritis and chronic obstructive pulmonary disease); - Occasional or current of use of drugs affecting ß-oxidation, including non-steroidal anti-inflammatory drugs, a-lipoic acid, valproic acid - Use of weight loss medication or lipid-lowering drugs - Altered thyroid hormone function tests or thyroid hormone treatment or altered somatotropic axis - Alcohol abuse according to the Diagnostic and Statistical Manual of Mental Disorders (DSM)-V diagnostic criteria - Vitamin/mineral or antioxidant supplementation - Subjects dropped out from the study since they refused to undergo full laboratory-instrumental examinations. |
Observational Model: Cohort, Time Perspective: Cross-Sectional
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Federico II University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Adherence to Mediterranean Diet by Predimed Questionnaire | December 2013 to September 2015 | No | |
Primary | Circulating Levels of Sirtuin 4 by ELISA method | December 2013 to September 2015 | No | |
Primary | Obesity by Body Mass Index | December 2013 to September 2015 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |